ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011